Allogene Therapeutics Stock (NASDAQ: ALLO) stock price, news, charts, stock research, profile.
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Other companies in Allogene Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).
Allogene Therapeutics has a consensus price target of $13.42.
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $2.575 last updated October 31, 2024 at 3:35 PM EDT.
There are no upcoming dividends for Allogene Therapeutics.
Allogene Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Allogene Therapeutics.
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.